Dataset Information


Epoxyeicosatrienoic acids mediate insulin-mediated augmentation in skeletal muscle perfusion and blood volume.

ABSTRACT: Skeletal muscle microvascular blood flow (MBF) increases in response to physiological hyperinsulinemia. This vascular action of insulin may facilitate glucose uptake. We hypothesized that epoxyeicosatrienoic acids (EETs), a family of arachadonic, acid-derived, endothelium-derived hyperpolarizing factors, are mediators of insulin's microvascular effects. Contrast-enhanced ultrasound (CEU) was performed to quantify skeletal muscle capillary blood volume (CBV) and MBF in wild-type and obese insulin-resistant (db/db) mice after administration of vehicle or trans-4-[4-(3-adamantan-1-ylureido)cyclohexyloxy]benzoic acid (t-AUCB), an inhibitor of soluble epoxide hydrolase that converts EETs to less active dihydroxyeicosatrienoic acids. Similar studies were performed in rats pretreated with l-NAME. CEU was also performed in rats undergoing a euglycemic hyperinsulinemic clamp, half of which were pretreated with the epoxygenase inhibitor MS-PPOH to inhibit EET synthesis. In both wild-type and db/db mice, intravenous t-AUCB produced an increase in CBV (65-100% increase at 30 min, P < 0.05) and in MBF. In db/db mice, t-AUCB also reduced plasma glucose by ?15%. In rats pretreated with l-NAME, t-AUCB after produced a significant ?20% increase in CBV, indicating a component of vascular response independent of nitric oxide (NO) production. Hyperinsulinemic clamp produced a time-dependent increase in MBF (19 ± 36 and 76 ± 49% at 90 min, P = 0.026) that was mediated in part by an increase in CBV. Insulin-mediated changes in both CBV and MBF during the clamp were blocked entirely by MS-PPOH. We conclude that EETs are a mediator of insulin-mediated augmentation in skeletal muscle perfusion and are involved in regulating changes in CBV during hyperinsulinemia.


PROVIDER: S-EPMC4269677 | BioStudies | 2014-01-01T00:00:00Z


REPOSITORIES: biostudies

Similar Datasets

2020-01-01 | S-EPMC7242354 | BioStudies
2012-01-01 | S-EPMC3528350 | BioStudies
2013-01-01 | S-EPMC3821736 | BioStudies
1000-01-01 | S-EPMC2844847 | BioStudies
2015-01-01 | S-EPMC4527317 | BioStudies
2016-01-01 | S-EPMC5050090 | BioStudies
2009-01-01 | S-EPMC2789559 | BioStudies
2017-01-01 | S-EPMC5568936 | BioStudies
2005-01-01 | S-EPMC4536910 | BioStudies
2017-01-01 | S-EPMC5921930 | BioStudies